In the S180 sarcoma, while the infiltrating CD4+ T-cells and CD19+ B-cells were significantly lower in tumors with RBP-J-/- DCs, the decease of CD8+ T-cells and NK-cells appeared not so impressive (see additional file 2). The gene discussed is CD19; the disease is sarcoma.